This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Reunion Neuroscience Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Reunion Neuroscience.
Key information
-14.0%
Earnings growth rate
47.3%
EPS growth rate
| Biotechs earnings growth | 40.7% |
| Revenue growth rate | 75.0% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 01 Aug 2023 |
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2026 | N/A | -83 | -87 | -82 | 1 |
| 3/31/2025 | N/A | -71 | -75 | -70 | 2 |
| 3/31/2024 | N/A | -39 | -52 | -47 | 2 |
| 3/31/2023 | N/A | -38 | -28 | -28 | N/A |
| 12/31/2022 | 5 | -74 | -34 | -33 | N/A |
| 9/30/2022 | 5 | -68 | -42 | -40 | N/A |
| 6/30/2022 | 5 | -57 | -46 | -44 | N/A |
| 3/31/2022 | N/A | -18 | -47 | -44 | N/A |
| 12/31/2021 | 1 | -20 | -45 | -42 | N/A |
| 9/30/2021 | 1 | -22 | -36 | -34 | N/A |
| 6/30/2021 | 1 | -24 | -28 | -26 | N/A |
| 3/31/2021 | 1 | -23 | -19 | -17 | N/A |
| 12/31/2020 | 0 | -16 | -12 | -10 | N/A |
| 9/30/2020 | 0 | -9 | -9 | -7 | N/A |
| 6/30/2020 | 0 | -5 | -5 | -4 | N/A |
| 3/31/2020 | 0 | -3 | -3 | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: REUN is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: REUN is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: REUN is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: REUN is forecast to have no revenue next year.
High Growth Revenue: REUN is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if REUN's Return on Equity is forecast to be high in 3 years time